Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
growth hormone-releasing hormone + pyridostigmine
- Development stage
- Preclinical
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Administration
- Intravenous (for Ghrh), Oral (for Pyridostigmine)
01
Overview
This is a combination of two agents—growth hormone-releasing hormone (GHRH), a hypothalamic peptide that stimulates the release of growth hormone (GH) from the anterior pituitary, and pyridostigmine, an acetylcholinesterase inhibitor. Pyridostigmine increases cholinergic tone and is believed to enhance GH secretion by inhibiting somatostatin release from the hypothalamus, thereby reducing its inhibitory effect on GH secretion. When administered together, GHRH directly stimulates GH release while pyridostigmine potentiates this effect by decreasing somatostatin-mediated inhibition. This combination has been used in research settings to assess pituitary function and investigate mechanisms regulating GH secretion in both healthy individuals and patients with endocrine disorders[1][2][3][4][6].
- Other names
- GHRH + pyridostigminegrowth hormone releasing hormone + pyridostigmine
02
Targets
GHRHR (Growth hormone-releasing hormone receptor)Acetylcholinesterase
Beyond the preview
Go deeper on growth hormone-releasing hormone + pyridostigmine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on growth hormone-releasing hormone + pyridostigmine.